Renal function and lipid metabolism in Japanese HIV-1-positive individuals 288 weeks after switching from tenofovir disoproxil fumarate to tenofovir alafenamide fumarate: a single-center, retrospective cohort study

Renal function and lipid metabolism in Japanese HIV-1-positive individuals 288 weeks after switching from tenofovir disoproxil fumarate to tenofovir alafenamide fumarate: a single-center, retrospective cohort study

Abstract Background Continued use of tenofovir disoproxil fumarate (TDF), an antiretroviral drug, causes renal function decline and tubular damage in individuals with HIV. While tenofovir alafenamide fumarate (TAF) may have less damaging effects, it causes weight gain and abnormal lipid metabolism....

Full description

Bibliographic Details
Main Authors: Kensuke Abe, Junji Imamura, Akiko Sasaki, Tomoko Suzuki, Satomi Kamio, Taku Obara, Toshihiro Ito
Format: Article
Language:English
Published: BMC 2024-02-01
Series:Journal of Pharmaceutical Health Care and Sciences
Subjects:
Renal function
Lipid metabolism
HIV
Tenofovir disoproxil fumarate
Tenofovir alafenamide fumarate
Online Access:https://doi.org/10.1186/s40780-024-00336-y

Internet

https://doi.org/10.1186/s40780-024-00336-y

Similar Items